Utilizing clinically annotated tissue microarrays (TMAs) from patients with RCC and a variety of other cancers, we measured tissue iron deposition and its association with RCC clinical features, including tumor pathology, TfR1 iron-importer expression, metastasis, and survival outcomes. Here, TFRC is linked to renal cell carcinoma.